Diabetes Lecture 1 Flashcards

1
Q

Epidemiology of Diabetes

A
25.8 million Americans have DM 
33-40% of males/females born in 2000 respectively will have DM (type 1 or type 2) in their lifetime
Pt.diagnosed at<40y/o will have a life expectancy by about 12-19 years
7th leading cause of death in the US
Diabetes is the number one cause:  
      1. Non-traumatic amputation
       2.  Kidney disease
         3. Blindness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification of Type 1 Diabetes

A

Absolute deficiency of insulin secretion
Autoimmune destruction of the pancreatic cells
Viruses that cause cell destruction; congenital rubella, coxsackievirus B, cytomegalovirus, adenovirus, and mumps

Prevalence: <10% of all DM cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classification of Type 2 Diabetes

A

Combination of complex metabolic disorders
1. Insulin resistance in muscle and adipose tissue
2. Progressive decline in pancreatic insulin secretion
3. Unrestrained hepatic glucose production
4. Other hormonal deficiencies
Amylin and incretin
Prevalence: >90% of all DM Cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Action of alpha cells, beta cells and amylin

A

alpha cell secrete glucagon
Beta cells secrete insulin
amylin suppresses insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Signs and Symptoms of Hyperglycemia

A

Polyuria: Frequent urination
Polydipsia: Inability to quench thirst
Polyphagia: Losing weight while eating a lot
Fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk Factors for Type 2 Diabetes

A
  • Overweight or obese state
  • Sedentary lifestyle
  • Family history of diabetes
  • Cardiovascular disease
  • Latino/Hispanic, NonñHispanic black, Asian American, Native American, or Pacific Islander ethnicity
  • Previously identified impaired glucose tolerance or impaired fasting glucose
  • Hypertension (>140/90 or on HTN meds)
  • Increased levels of triglycerides (>250), low concentrations of high-density lipoprotein cholesterol (<35), or both
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk Factors for GDM

A

History of gestational diabetes
History of delivery of an infant with a birth weight >9 lbs
Polycystic ovary syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diabetes Screening

A
  1. Asymptomatic people with a BMI greater than or equal to 25 kg/M2 in adults of any age and who have one or more additional risk factors for DM
  2. In those without these risks, testing should start at age 45
  3. If tests are negative with these risk factors, test again at 3 year intervals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A1C and Daily Blood Glucose

A
A1C                 Mean Glucose
6                           126
7                           154
8                           183
9                           212
10                         240
11                          269
12                         298
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnostic Criteria for Type 1 and 2 Diabetes

A

Lab Normal Pre-Diabetes Diabetes
A1C < 5.7 % 5.7-6.4% ≥ 6.5%

Fasting
Plasma
Glucose < 100 mg/dL 100-125 mg/dL ≥ 126 mg/dL

Oral Glucose
Tolerance Test <140 mg/dL 140-199 mg/dL ≥ 200 mg/dL

Random Glucose
+ Symptoms N/A N/A ≥ 200 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment Goals

A

-A1C: <180mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pre- Diabetes

A
If a patient is determined to have pre-diabetes (IGT, IFG, or A1C 5.7-6.4%), then metformin could be considered as a therapy, especially if any of the following are met:
      1. BMI > 35kg/m2
       2. <60 years of age
       3. Women with prior GDM
Annual monitoring for development of DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Complications of Diabetes

A
Macrovascular Complications
     1. Coronary artery disease 
      2. HTN
       3. Dyslipidemia
Microvascular Complications
    1. Retinopathy 
     2. Neuropathy
     3. Nephropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Non- Pharmacological Therapy

A

Exercise
1. 30 minutes for most days of the week

Diet

1. Avoid foods high in saturated fats, carbohydrates and sugar
 2. Increase fiber
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CAD Complication Management

A

ASA 81mg daily

Men >50 years of age or women >60 years of age with at least one additional risk factor (family history of CVD, HTN, smoking, dyslipidemia, or albunemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HTN Complication Management

A

Goal: 140/80…..130/80 for certain populations

ACE-I or ARB

17
Q

Dyslipidemia Complication Management

A

Goal: LDL <100

Statin initiate therapy for those with a PMH of an MI,or greater than 40 y/o with other risk factors

18
Q

Retinopathy Complication Management

A

Manage HTN and glucose

Laser treatment

19
Q

Neuropathy Complication Management

A

Manage HTN and glucose ï
Peripheral:
Numbness/tingling in the hands and feet (yearly foot exams)
Gabapentin (2400-3600mg daily in divided doses titrate up due to drowsiness), Lyrica and Cymbalta (both FDA approved), TCA ís (dose at night)

Autonomic:
Erectile dysfunction; PDE-5 inhibitors
Gastropyresis: Reglan and erythromycin
Constipation: Stool softeners

20
Q

Nephropathy Complication Management

A

Manage HTN and glucose
ACE-I or ARB to help slow progression from micro to
macroalbumenia

21
Q

Special Populations of DM

A

Gestational DM
Children and adolescents
Older adults

22
Q

Incidence of GDM

A

Complicates ~7% (~200,000 cases annually) of all pregnancies in the U.S.
Prevalence may range from 1 to 14% of pregnancies depending on the population studied

23
Q

Complications of GDM

A
Macrosomia
      Cesarean delivery
      Shoulder dystocia and birth trauma
Neonatal metabolic problems ï Perinatal mortality
Hypertension/preeclampsia
24
Q

Risk Factors of GDM

A
  • > 25 year old
  • Overweight/obese
  • Family history of DM2 (first degree relative)
  • History of abnormal glucose metabolism
  • History of poor obstetric outcomes
  • History of delivery of an infant > 9 lbs
  • History of polycystic ovarian disease
  • Ethnicity: Latino/Hispanic, non-Hispanic black, Asian American, Native American, Pacific Islander
25
Q

Diagnostic Criteria of GDM

A
  • Screen at first prenatal visit in those with risk factors

- If a woman does not have known DM test using OGTT at 24-28 weeks

26
Q

Treatment for GDM

A
  • Dietary modifications and insulin remain first line treatment for GDM
  • Clinicaltrialsarecurrentlyinvestigatingnewer options with oral hypoglycemic agents and insulin analogs
  • Treat meant plans should be individualized keeping the safety of both the mother and fetus in mind
    Oral Agents
    Biguanides and TZD ís: NOT RECOMMENDED
    Sulfonylureas: Glipizide and Glyburide possible treatment options
27
Q

Follow for GDM

A
  • If a women does have GDM they need to be tested 6-12 weeks postpartum
  • If a women does have GDM they should be screen every 3 years for the development of DM or pre-diabetes
28
Q

Children and Adolescence

A

3/4 of all type 1 DM cases are diagnosed before the age of 18

Differences compared to adults:

1. Changes in insulin sensitivity due to hormone changes
2. Growth patterns
3. Supervision at school and daycare
4. Unique vulnerability to hypoglycemia and DKA
29
Q

Goals for Children and Adolescence

A

Lax compared to adults because of their risk of hypoglycemia (unable to detect and act on the signs and if the pt. < 5 years of age they have a risk of developing severe neurological damage from hypoglycemia)

30
Q

Incidence for Older Adults

A

~ 20% of the population over the age of 65 has DM

Increased rates of
Premature death
Functional and cognitive impairment
Co-morbid conditions (heart disease, stroke etc)

31
Q

Overall Goals for Older Adults

A

Should be the same for younger adults if the patient
Has significant life expectancy
Functional
Cognitively intact

32
Q

Therapy Goals for Older Adults

A
  • Glycemic goal may be relaxed ñ Want to avoid hypoglycemia

- Treat all heart conditions and provide all therapy to patients that are able to benefit from this